This poster describes the AV Avantage HPV E6 Test and the results from a small clinical pilot study. The AV Avantage HPV E6 Test uses high affinity mAb for the specific capture and detection of high-risk HPV-E6 oncoproteins in a lateral flow–based format. Presented at: 26th International Papillomavirus Conference, July 3, 2010; Montreal, Canada.
Author(s): Berard-Bergery M, Bisht A, Ho M, et al
Corporate author(s): PATH, Arbor Vita Corporation, Johns Hopkins Bloomberg School of Public Health
Publication date: July 2010
363 KB PDF
Hard copies are not available.
Some digital files may be saved at low resolutions to conserve file size. Versions with higher quality may be available; see the contact information below to enquire.
Related regions: Global
- Health technologies > Diagnostics
- Reproductive health > Cervical cancer prevention
- Reproductive health > Sexually transmitted infections
For more information…
Contact: PATH Publications
Mailing address: PATH, PO Box 900922, Seattle, WA 98109 USA